Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Xencor Doses First Patient in Phase 1 Study of XmAb20717 Dual Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors

  (July 12, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Pro AV,Presentors,Business,Business Issues,Presentation,Events, Inc.,Medicine,Disease,Cancer,Surgery,Medication,Children,Science,Medical,Cancer,Business,Other,

-->

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved